Professor Ian Freckelton

Professor Ian Freckelton, King’s Counsel, has made extensive contributions to health law and policy through his roles as an academic, researcher and teacher and through his involvement in national committees. His extraordinary contributions to heath law have been both considerable and influential, particularly as the founder of the Journal of Law and Medicine, which attracts […]

Professor Aleksandra Filipovska

Professor Aleksandra Filipovska is internationally renowned for her pioneering work in mitochondrial genomics and disease. She is Deputy Director of the ARC Centre for Synthetic Biology and NHMRC Senior Research Fellow at the University of Western Australia. As co-director at the Mito Foundation, Professor Filipovska plays a key role in advocating for the mitochondrial disease […]

Professor Peter Ebeling

Professor Peter Ebeling’s national and international recognition for excellence in health and medical science is demonstrated by key leadership roles at the highest level, including as first non-North American President of the American Society of Bone and Mineral Research, Past-president of the Endocrine Society of Australia and Australian and New Zealand Bone and Mineral Society, […]

Professor Dominic Dwyer

Professor Dominic Dwyer is a clinical virologist and infectious diseases physician, trained in Sydney with doctoral research undertaken at the Institut Pasteur, Paris. He is the NSW Director of Public Health Pathology, and Director of the Institute Of Clinical Pathology and Medical Research (ICPMR) at Westmead. He is an expert in emerging infections, an investigator […]

Professor Denise Doolan

Professor Denise Doolan is a Professorial Research Fellow and Acting Director of the Australian Institute of Tropical Health and Medicine at James Cook University. She is a molecular immunologist with multidisciplinary research focuses on developing therapeutics and diagnostics for infectious diseases that impact global public health. Professor Doolan’s research has provided critical insights into multiple […]

Professor Ian Davis

Professor Ian Davis is a medical oncologist with over 30 years’ experience and primary clinical and research focus in genitourinary cancers. He founded and chairs the ANZUP (Australian and New Zealand Urogenital and Prostate) Cancer Trials Group and is the global co-chair of international ANZUP ENZAMET trial. This trial demonstrated improved survival with enzalutamide for […]

Professor Phillip Darcy

Professor Phillip Darcy is an NHMRC Principal Research Fellow and Group Leader at the Peter MacCallum Cancer Centre. His work has been pivotal in developing novel T cell-based immunotherapy approaches for cancer patients. In particular, his studies involving the development of technology using gene‐modified T cells expressing chimeric antigen receptors (CARs) in preclinical models has […]

Professor Jennifer Couper

Professor Jenny Couper is a practising clinician and researcher who leads innovations for children at-risk or with type 1 diabetes. Her research is in the prevention of type 1 diabetes and the prevention of cardiovascular complications. She heads the first global investigation of the early life origins of type 1 diabetes and co-leads prevention trials. […]

Professor Leonid Churilov

Professor Leonid Churilov is a clinical biostatistician who led complex and comprehensive design and analysis of acute and recovery stroke trials that resulted in global changes in clinical practice, and are internationally recognized through multiple publications in the highest impact medical journals including NEJM, The Lancet and JAMA. Professor Churilov led the development, and wide […]

Professor David Burgner

Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He is Education Officer for the World Society of Paediatric Infectious Diseases. Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection […]

Professor Susan Fletcher

Professor Susan Fletcher is Senior Principal Research Fellow at Murdoch University and in 2020 was appointed Chief Scientific Officer (fractional position) at ASX-listed biotech PYC Therapeutics. Alongside her collaborator Professor Steve Wilton, she pioneered ‘molecular drugs’ to treat inherited disease by altering the gene message to overcome disease-causing mutations. In 2016, 2019 and 2021, the […]

Professor Bruce Robinson

Professor Bruce Robinson has received national and international recognition through awards and invitations to speak and write on endocrine tumours. He has forged links with countries in SE Asia including Vietnam, Cambodia, Myanmar and China and has assisted in training hundreds of health professionals from these countries. He has reformed curricula locally and is working […]

Professor Warwick Anderson

Professor Warwick Anderson is a distinguished historian of the biomedical and biological sciences, whose research has transformed our understanding of colonial and tropical medicine, and helped to explain the development of global health. His conceptual histories of the recent biomedical sciences, especially immunology, have enriched scientists’ knowledge of the development of their discipline and enhanced […]

Professor Kaarin Anstey

Professor Kaarin Anstey is a world leader in cognitive ageing and dementia risk reduction. Her program of research has contributed to the evidence base on dementia prevention through identification and quantification of risk factors for dementia, the development of risk assessment tools and implementation of interventions. Professor Anstey’s work has directly informed informed public policy […]

Professor Jodie Dodd

Professor Jodie Dodd, a maternal fetal medicine specialist, is recognised as being at the forefront of a paradigm shift in the management and prevention of obesity in pregnancy, which has occurred worldwide over the last decade. The outcomes of her research, a series of unique and harmonised RCTs and associated systematic reviews and individual participant […]

Professor Pat Dudgeon

Pat Dudgeon is Bardi woman from the Kimberley in Western Australia. She was Australia’s first Aboriginal psychologist and has had an outstanding career in Aboriginal mental health and wellbeing, developing innovative methodologies to include deep Indigenous knowledge in health and medical sciences research and services. She has showede how the specific historical, socio-economic, political, cultural […]

Professor Ron Grunstein

Professor Ron Grunstein MBBS MD PhD FRACP FAHMS AM is the leading sleep medicine clinician-researcher in Australia and one of the world leaders in this discipline. He has been engaged in the field from its early origins and has played a major role in the development of the academic, clinical, professional and policy aspects of […]

Professor Rana Hinman

Prof Rana Hinman is a physiotherapist who leads research focussed on improving the health of people living with osteoarthritis. Her multi‐disciplinary research produces and translates innovative, robust and pragmatic evidence about non‐drug, non‐surgical approaches to managing osteoarthritis symptoms, including novel methods of service delivery. Her research has informed Australian and international clinical practice guidelines, as […]

Professor Harriet Hiscock

Professor Harriet Hiscock is internationally renowned for her expertise and leadership in sleep and mental health research. She leads world class health services research to develop, test and implement evidence-based interventions to improve the quality, accessibility, and value of healthcare for paediatric common, high burden conditions. As a clinician researcher, she has published over 180 […]

Professor David Ching Siang Huang

Professor David Huang is a biomedical researcher who made fundamental research discoveries on programmed cell suicide (apoptosis) that laid the foundations for the discovery and development of a novel class of anti-cancer drugs. He made critical contributions towards revealing how BCL2, often overactive in blood cancers, and its relatives block cell death thereby uncovering how […]

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.